References
- Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care 2001; 24: 1590–5
- Nilsson PM, Gudbjörnsdottir S, Eliasson B, Cederholm J. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes: Data from the National Diabetes Register in Sweden. Diabetes Metab 2004; 30: 261–8
- Al-Delaimy WK, Willett WC, Manson JE, Speizer FE, Hu FB. Smoking and mortality among women with type 2 diabetes: The Nurses’ Health Study cohort. Diabetes Care 2001; 24: 2043–8
- Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 1993; 306: 1313–18
- Sawicki PT, Didjurgeit U, Muhlhauser I, Berger M. Behaviour therapy versus doctor's anti-smoking advice in diabetic patients. J Intern Med 1993; 234: 407–9
- Fowler PM, Hoskins PL, McGill M, Dutton SP, Yue DK, Turtle JR. Anti-smoking programme for diabetic patients: The agony and the ecstasy. Diabet Med 1989; 6: 698–702
- Malarcher AM, Ford ES, Nelson DE, Chrismon JH, Mowery P, Merritt RK, et al. Trends in cigarette smoking and physicians’ advice to quit smoking among people with diabetes in the US. Diabetes Care 1995; 18: 694–7
- Haire-Joshu D, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 2004; 27(Suppl 1)S74–5
- Olivarius de Fine N. Diabetes care today: Not everyone should have intensive multipharmacological treatment. Scand J Prim Health Care 2004; 22: 67–70
- Wändell PE. Quality of life of patients with diabetes mellitus: An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care 2005; 23: 68–74
- Persson L-G, Lindström K, Lingfors H. Quality improvement in primary health care using computerised journal, exemplified by a smoking cessation programme for diabetic patients. Scand J Prim Health Care 2000; 18: 252–3
- Heatherton TF, Kozlowski LT, Frecker RC, Fagerström K-O. The Fagerström test for nicotine dependence: A revision of the Fagerström tolerance questionnaire. Br J Addict 1991; 86: 1119–27
- Hjalmarson A, Franzon M, Westin Å, Wiklund O. Effect of nicotine nasal spray on smoking cessation: A randomized, placebo-controlled, double-blind study. Arch Intern Med 1994; 154: 2567–72
- Spencer E, Swanson T, Hueston WJ, Edberg DL. Tools to improve documentation of smoking status: Continuous quality improvement and electronic medical records. Arch Fam Med 1999; 8: 18–22
- Bakkevig O, Steine S, von Hafenbrädl K, Laerum E. Smoking cessation. A comparative, randomised study between management in general practice and the behavioural programme SmokEnders. Scand J Prim Health Care 2000; 18: 247–51
- Vartiainen E, Seppala T, Lillsunde P, Puska P. Validation of self reported smoking by serum cotinine measurement in a community-based study. J Epidemiol Community Health 2002; 56: 167–70
- Nilsson P, Lundgren H, Söderström M, Fagerström K-O, Nilsson-Ehle P. Effects of smoking cessation on insulin and cardiovascular risk factors: A controlled study of 4 months’ duration. J Intern Med 1996; 240: 189–94
- Martinez ME, Reid M, Jiang R, Einspahr J, Alberts DS. Accuracy of self-reported smoking status among participants in a chemoprevention trial. Prev Med 2004; 38: 492–7
- Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martinez-Gonzalez MA. Intervention study for smoking cessation in diabetic patients: A randomized controlled trial in both clinical and primary care settings. Diabetes Care 2000; 23: 1455–60